This paper will review the current serologic tests to Equine infectious anemia (EIA) has been recognized diagnose infections with EIAV, discuss limitations of as an important viral disease of members of the horse the procedures, and suggest improvements based on family since its "filterable virus" etiology was proven early in the twentieth century. 49 Only since the 1970s EIAV and the horse have we been able to diagnose infection with equine infectious anemia virus (EIAV) accurately with the use The EIAV is a member of the lentivirus subfamily of serodiagnostic methods. 6, 7 Early attempts to define of retroviruses and shares morphologic, antigenic, and specific diagnostic tools for EIA failed in part because genetic characters with the other lentiviruses. 17 The of a lack of suitable in vivo laboratory animal models major core protein of EIAV is a product of the viral and in vitro techniques for virus propagation, as well gag gene, 45 has a molecular weight of 26,000 daltons as the tendency of EIAV to undergo "antigenic drift." 24 (p26), 37 represents about 40% of the virion mass, 32 The recognition of the highly mutable type-or subtype-and has group and interspecies antigenic determispecific antigens of EIAV which stimulated neutraliz-nants. 12, 30, 31 The major core protein appears to be highing antibodies suggested that a widely applicable diag-ly conserved between EIAV isolates, 44 and the imnostic test for the disease would not be forthcoming. 21 munodominant regions of the protein have been Complement fixation and precipitin tests were tried elucidated. 4 Antibodies to the major core protein are but held little promise as accurate and/or practical di-detected in the AGID test because the p26 antigen agnostics. 21, 43 Horse inoculation tests were standard-predominates in antigen preparations. Occasional reized for the diagnosis of EIA, 3 but were expensive, actions to the pl5 protein of EIAV have been noted wasteful of equine resources and required facilities in in the AGID test. 25, 47 which to isolate the recipient. As a result of these lim-When horses are exposed to EIAV by natural or itations, this test never received wide usage. artificial routes, the virus replicates in cells of the In the early 1970s EIAV antigen for use in serologic monocyte/macrophage cell lineage 29 and is released into tests was extracted from the spleens of horses which the bloodstream prior to the onset of fever or other had been infected experimentally, or from virus which clinical signs of disease. 22 This first viremia can be had been cultivated in equine leukocytes and puri-detected as early as 5-7 days after inoculation. The fied 34, 35 Horses with clinical signs of EIA responded infected horse produces detectable humoral immune by producing detectable antibodies to these antigens. responses to EIAV proteins as early as 12 days after The use of the procedure perfected by Ouchterlony infection, but usually becomes AGID test-positive by and proved effective. 8, 33 These discoveries led to the "incubation period," defined as the time of exposure development of the widely accepted and internation-until the first AGID test-positive sample, was docually standardized agar gel immunodiffusion (AGID) merited.... True latent infections with EIAV have not test for antibodies to EIAV. 38, 39 This test has become paralleled those seen with human immunodeficiency the "gold standard" for the diagnosis of EIAV infec-virus (HIV) infections, but 1 report documented an tions, the test by which newer formats for the detection incubation period of 85 days in a foal from a positive of antibodies to EIAV are compared.
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mare. 9 Once a horse is infected with EIAV, it assumed that
Strengths and weaknesses of serodiagnostic tests for EIA
AGID test. The AGID test has stood the test of time and is accepted as the international standard for diagnosis of EIA. Extensive testing was accomplished to correlate negative and positive AGID test results with the presence of EIAV in the blood of horses. 8, 40 Blood from AGID positive and negative horses was inoculated into susceptible horses to validate that horses with EIA antibody were infected and that negative horses were not infected. Because of this proven reliability, the AGID test has been used throughout the world as the primary method to certify horses free of EIA so that they can be exported, moved interstate and intrastate, be sold and be accepted at shows and tracks. Most of the testing today is to qualify animals for movement.
The AGID test has the recognized limitations of all serologic tests. For example, serum samples collected from horses during the first clinical episode induced by EIAV often will test negative for antibodies in the AGID test because the horses have not had sufficient time to mount primary immune responses to the p26 protein. These horses must be sampled again in 10-14 days for confirmation. These reactions are expected and are not considered true "false negative" reactions, although they do represent cases where the horse is EIAV-positive but AGID test-negative. Positive reactions can occur when foals obtain colostral passive immunity from their test-positive dams, but the foal may not be infected. Although this is not a true "false positive" reaction per se, it could be misinterpreted as meaning the foal is infected with EIAV. In the majority of cases, foals of test-positive mares are not infected at birth and can be raised free of the infection?
When quality reagents are used and when the accepted procedures for testing are followed, easily interpreted results are obtained within 24-48 hours of the time the test is set up. 41 Antigen sources for the AGID test originally were derived from the spleens of infected horses but have been supplanted in most areas of the world by antigen derived from infected cell cultures. 25 The AGID test has been used to help eradicate EIA from horse populations throughout the world. 10 In the United States the number of tests for EIA has increased from 82,777 in 1972 to 993,712 in 1991; the percentage of positive tests has decreased from 4.0 to 028. 20, 41 The apparent decrease is primarily due to the aggressive AGID testing to restrict movement of positive horses. Many of these horses are eventually destroyed. There have been few reports of discrepencies in test reactions of positive horses, even though they are tested at least twice. Discrepencies due to misidentification of the horse are more commonly seen than those due to test problems. However, there are three reports of horses with consistent and/or persistent equivocal or negative AGID reactions from which EIAV has been documented. 15, 28, 48 These individuals appear to have low levels of anti-p26 antibodies in their serum and give reactions that are interpreted as AGID test-negative by the majority of well-trained diagnosticians. These serums often will give unequivocal positive reactions in other formats for anti-p26 antibodies or will react with other EIAV proteins with greater intensity (Table 1) . 18 Individuals with these types of reactions seem to occur in low frequency in the population but have the potential to spread EIAV in populations with no history of AGID test-positive horses.
CELISA test. The competitive ELISA (CELISA) test for antibodies to the p26 antigen of EIAV has been licensed since the late 1980s in the United States. 27 This test has the advantage of being less subjective than the AGID test, and could be made completely objective if an ELISA reader is used. The antibody status of a horse can be established in 2 hours by comparing the color produced by the test sample to that produced by a weak positive sample. Correlation of AGID and CELISA results are excellent if standardized protocols are followed. 41 Discordant results can occur by two major mechanisms. The most common reason for a positive CELISA result with a negative AGID interpretation is because of the low level of antibody to the p26 antigen in the sample, which is easier to detect in the CELISA test (Table 1 , Mare 4, Flicker, CD 141, Pony 719). Another possible reason for discordant results is the presence of antibodies in the sample directed at the interspecies determinant of the p26 antigen which will not be detected in the AGID test. These antibodies could occur in the horse following exposure to related lentiviruses in nature. These should be judged as false positive results if only anti-
Recommendations p26 antibodies are detected in confirmatory retests and in immunoblot tests (see below). An example of this
The AGID test has proven its value in the control of EIA. The test has limitations based primarily on its type of sample is presented in Table 1 (sample desiginability to detect low levels of antibody to the p26 nated RCLS).
Immunoblot test. At the present time, the immu-antigen. It remains the test of choice for routine testing of samples in areas where EIA is infrequently diagnoblot procedure for detection of antibodies to EIAV proteins is only a research tool. Despite that limited use, the immunoblot test has provided us with insight into the kinetics of immune responses of EIAV-infected horses, 19 definition of antigens recognized by infected horses, 42 and has provided us with an additional test to confirm the antibody reactivity of serum samples from horses with equivocal test reactions 18 The immunoblot test also has helped us define the presence of group-specific antigenic determinants of the envelope proteins of EIAV (gp90 and gp45), which are analogous to the surface unit (gp120) and transmembrane (gp41) proteins of the HIV.
The database on HIV serology will help put the immunoblot procedure into perspective. The immunoblot test is recognized as the confirmatory test for antibodies to HIV. Samples that give repeated positive results in the screening ELISA test for antibodies to the major core protein of the HIV (p24) are tested in immunoblot and reported positive only if the serum reacts with the major core and one or both of the envelope proteins. Samples that react only with the p24 protein currently are recognized as false positive reactions.
nosed. This statement assumes that a rapid laboratory result is not needed.
If the horses reside in the great swampland of Brazil, the Pantanal, where 40% of the horses are estimated to be infected with EIAV and where rapid test results are needed because of the remote location of the horses, the CELISA test becomes the test of choice. In this application, the rapid turnaround time allows the rounding up, testing and segregation of positives to occur on the same day, a distinct advantage. Because the CELISA is an enzyme-based assay, it requires careful handling to maintain stability of the detection system, which may limit some field applications.
Despite the fact that the gp90 and gp45 proteins of EIAV are found in low quantities in the virion, they are potent antigens and proportionally stimulate higher levels of antibody than the p26 antigen. This is evident in immunoblot tests and is consistent with observations of HIV and man. Because each of the 3 major EIAV proteins of EIAV (gp90, gp45, and p26) have group-specific antigenic determinants, the prototype cell-adapted strain of EIAV can be used in the immunoblot test to detect antibodies in serums from horses in diverse geographic settings. After an infection, antibodies to gp90 are detected first, then those directed against p26 are detected. 19 These positive reactions can be detected before a positive AGID reaction is observed and may be evident after the first viremia but before the first febrile episode associated with EIAV replication.
Whether the AGID test or CELISA test is used, periodic quality control checks are recommended to assure the standardization of test results between laboratories and to ensure the highest possible accuracy. In the United States, these are accomplished with annual check-test samples sent to participating laboratories from the USDA. A satisfactory result, based on a statistical evaluation of results from participating laboratories, is required to maintain the official approved status of the laboratory. A weak positive reference sample, which can be supplied by a reference laboratory, can be used to ensure the sensitivity of the test is being maintained. An alternate procedure, in the absence of an official body with the responsibility to assure competency, would be to obtain several commercial kits for the diagnosis of EIA and to verify results of difficult and routine samples at regular intervals.
The immunoblot test has helped to clarify the status of horses with questionable reactions in the official tests for EIA (Table 1 ). In some cases, it is clear that the AGID test is not as sensitive as the CELISA (Pony 719, day 15); in others, it is clear that the CELISA test is not as specific as the AGID test (Sample RCLS). One lesson is clear, however; only with the availability of confirmatory tests will we be able to improve our diagnosis of this infection. As the database on EIAV genes and antigens increases, 1, 2, 4, 5, 11, 36, 42 novel approaches to the delivery of accurate and practical diagnostic tests for EIA will emerge. If changes were to be made today, test kits should include determinants from several EIAV proteins and utilize a format that uses environmentally stable reagents and detection systems. These tests should require less interpretation than the AGID test and should be more "user friendly," which would make practitioner use more attractive. In the absence of effective vaccines for this disease, control is dependent on widescale testing to identify and control the movement of infected horses. This method increases in effectiveness as a higher percentage of the population at risk is tested.
